Junimin

Copper gluconate, Manganese gluconate, Potassium iodide, Sodium selenite, Zinc gluconate, the active ingredients in Junimin, are mineral supplements presented as an intravenous solution for intravenous use. It provides essential trace elements for patients with trace element deficiency or requiring nutritional support.

GNH USA supplies Junimin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Junimin is used to address deficiencies of essential trace elements and to support metabolic processes in clinical nutrition. - Trace element deficiency: restores copper, manganese, iodine, selenium and zinc levels. - Post‑surgical nutritional support: supplies needed minerals during recovery. - Chronic kidney disease: helps compensate for losses of trace elements during dialysis.

Junimin may be associated with several adverse reactions following intravenous administration.

Common Side Effects: - Infusion site irritation: mild pain or erythema at the injection site. - Nausea or mild gastrointestinal upset. - Transient headache or dizziness. - Metallic taste during infusion. - Low‑grade fever within the first few hours. - Mild skin rash.

Serious or Rare Side Effects: - Anaphylactic reaction: difficulty breathing, swelling, or hypotension. - Severe hypotension or shock during infusion. - Electrolyte imbalance leading to cardiac arrhythmia. - Acute renal dysfunction in susceptible patients. - Severe thrombophlebitis at the infusion site.

Before administering Junimin, consider the following safety measures. - Baseline assessment: evaluate patient’s trace element status and renal function. - Hypersensitivity: avoid use in individuals with known allergy to any component. - Thyroid disorders: monitor thyroid function because of iodine content. - Hepatic impairment: adjust dosing or monitor closely in liver disease. - Concomitant chelators: avoid simultaneous use of strong metal‑binding agents. - Store at 2‑8°C: keep refrigerated, protect from light, do not freeze or shake.

Junimin can interact with other medicines and nutrients; awareness of the level of interaction is essential.

Major Interactions (Avoid): - High‑dose oral iron supplements: may compete for absorption and reduce efficacy. - Parenteral nutrition formulas containing overlapping trace elements: risk of overload. - Chelating agents such as EDTA: bind administered minerals and diminish therapeutic effect.

Moderate Interactions (Monitor Closely): - Thyroid hormone therapy: excess iodine may alter hormone levels. - Anticoagulants (e.g., warfarin): zinc can affect platelet aggregation. - Loop diuretics: may exacerbate electrolyte shifts when combined with trace element infusion.